- Medicare’s GLP‑1 Bridge starts July 1, 2026, giving eligible beneficiaries access to Eli Lilly weight‑loss drugs Zepbound and Foundayo for a $50 monthly copay.
- EU CHMP recommended Eli Lilly's Jaypirca (pirtobrutinib) for CLL across lines after Phase 3 showed efficacy and tolerability; European Commission decision expected in one to two months.
TradingView
Key facts: Medicare GLP‑1 Bridge starts Jul 1; CHMP backs Jaypirca
- Sources
- TradingView
- Markets
- Stocks
- Active symbols
- NYSE:LLY
- Language
- English
Medicare’s GLP‑1 Bridge starts July 1, 2026, giving eligible beneficiaries access to Eli Lilly weight‑loss drugs Zepbound and Foundayo for a $50 monthly copay.EU CHMP recommended E